Company: Vesigen Therapeutics
Job title: CEO
Robert Millman, J.D., is a serial life science entrepreneur and is currently the Co-Founder & CEO of Vesigen Therapeutics and CEO of NControl Therapeutics. Prior to Vesigen, he founded PhotoRegulon, now Nayan, and was a founder and CEO of Semma Therapeutics. As a Managing Director at MPM Capital, he helped form and served as the start-up IP Counsel of several MPM portfolio companies including Epizyme, iPierian, and Verastem. Robert founded and led CoStim Pharmaceuticals as its first President, a company focused on cancer immunotherapy. Robert has also served as an IP counsel for several important portfolio companies during funding, development, or transactions including Peplin, Syndax, and Valeritas. Prior to joining MPM, Robert was Chief IP Counsel at Alnylam Pharmaceuticals Inc., the Chief IP Counsel at Infinity Pharmaceuticals, Inc., the Chief IP Counsel at Celera Genomics, and Patent Counsel at Millennium Pharmaceuticals, Inc. Earlier in his career, Robert was an associate at Morrison and Foerster LLP and a patent agent/specialist at Sterne, Kessler Goldstein and Fox, LLP. Robert received his J.D. degree from the Washington College of Law at The American University, an M.S. degree in Genetics from Washington State University and a B.S. degree in Biochemistry from the University of California, Riverside.
Panel Discussion: Commercialization, Partnerships & Regulation 4:30 pm
Download full event guide for session detailsRead more
day: Day Two